Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $305 million versus the consensus estimate of $298.9 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.